Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Equine herpesvirus type 1-mediated oncolysis of human glioblastoma multiforme cells.

Courchesne MJ, White MC, Stanfield BA, Frampton AR Jr.

J Virol. 2012 Mar;86(5):2882-6. doi: 10.1128/JVI.06296-11. Epub 2011 Dec 28.

2.

The histone deacetylase inhibitor valproic acid enhances equine herpesvirus type 1 (EHV-1)-mediated oncolysis of human glioma cells.

White MC, Frampton AR Jr.

Cancer Gene Ther. 2013 Feb;20(2):88-93. doi: 10.1038/cgt.2012.89. Epub 2013 Jan 11.

PMID:
23306611
3.

Equus caballus major histocompatibility complex class I is an entry receptor for equine herpesvirus type 1.

Kurtz BM, Singletary LB, Kelly SD, Frampton AR Jr.

J Virol. 2010 Sep;84(18):9027-34. doi: 10.1128/JVI.00287-10. Epub 2010 Jul 7.

4.

Varicella zoster virus infection of malignant glioma cell cultures: a new candidate for oncolytic virotherapy?

Leske H, Haase R, Restle F, Schichor C, Albrecht V, Vizoso Pinto MG, Tonn JC, Baiker A, Thon N.

Anticancer Res. 2012 Apr;32(4):1137-44.

PMID:
22493342
5.

MicroRNA-Attenuated Clone of Virulent Semliki Forest Virus Overcomes Antiviral Type I Interferon in Resistant Mouse CT-2A Glioma.

Martikainen M, Niittykoski M, von und zu Fraunberg M, Immonen A, Koponen S, van Geenen M, Vähä-Koskela M, Ylösmäki E, Jääskeläinen JE, Saksela K, Hinkkanen A.

J Virol. 2015 Oct;89(20):10637-47. doi: 10.1128/JVI.01868-15. Epub 2015 Aug 12.

6.

Combination of measles virus virotherapy and radiation therapy has synergistic activity in the treatment of glioblastoma multiforme.

Liu C, Sarkaria JN, Petell CA, Paraskevakou G, Zollman PJ, Schroeder M, Carlson B, Decker PA, Wu W, James CD, Russell SJ, Galanis E.

Clin Cancer Res. 2007 Dec 1;13(23):7155-65.

7.

In vitro screen of a small molecule inhibitor drug library identifies multiple compounds that synergize with oncolytic myxoma virus against human brain tumor-initiating cells.

McKenzie BA, Zemp FJ, Pisklakova A, Narendran A, McFadden G, Lun X, Kenchappa RS, Kurz EU, Forsyth PA.

Neuro Oncol. 2015 Aug;17(8):1086-94. doi: 10.1093/neuonc/nou359. Epub 2015 Jan 20.

8.

Glycoproteins D of equine herpesvirus type 1 (EHV-1) and EHV-4 determine cellular tropism independently of integrins.

Azab W, Osterrieder N.

J Virol. 2012 Feb;86(4):2031-44. doi: 10.1128/JVI.06555-11. Epub 2011 Dec 14.

9.

Equid herpesvirus type 4 uses a restricted set of equine major histocompatibility complex class I proteins as entry receptors.

Azab W, Harman R, Miller D, Tallmadge R, Frampton AR Jr, Antczak DF, Osterrieder N.

J Gen Virol. 2014 Jul;95(Pt 7):1554-63. doi: 10.1099/vir.0.066407-0. Epub 2014 Apr 10.

PMID:
24722677
10.

Oncolytic virus therapy for glioblastoma multiforme: concepts and candidates.

Wollmann G, Ozduman K, van den Pol AN.

Cancer J. 2012 Jan-Feb;18(1):69-81. doi: 10.1097/PPO.0b013e31824671c9. Review.

11.

Enhanced antiglioma activity of chimeric HCMV/HSV-1 oncolytic viruses.

Shah AC, Parker JN, Gillespie GY, Lakeman FD, Meleth S, Markert JM, Cassady KA.

Gene Ther. 2007 Jul;14(13):1045-54. Epub 2007 Apr 12.

PMID:
17429445
12.

Single amino acid residue in the A2 domain of major histocompatibility complex class I is involved in the efficiency of equine herpesvirus-1 entry.

Sasaki M, Kim E, Igarashi M, Ito K, Hasebe R, Fukushi H, Sawa H, Kimura T.

J Biol Chem. 2011 Nov 11;286(45):39370-8. doi: 10.1074/jbc.M111.251751. Epub 2011 Sep 26.

13.

Vesicular stomatitis virus as an oncolytic agent against pancreatic ductal adenocarcinoma.

Murphy AM, Besmer DM, Moerdyk-Schauwecker M, Moestl N, Ornelles DA, Mukherjee P, Grdzelishvili VZ.

J Virol. 2012 Mar;86(6):3073-87. doi: 10.1128/JVI.05640-11. Epub 2012 Jan 11. Erratum in: J Virol. 2013 Feb;87(3):1923.

14.

Engineered herpes simplex viruses efficiently infect and kill CD133+ human glioma xenograft cells that express CD111.

Friedman GK, Langford CP, Coleman JM, Cassady KA, Parker JN, Markert JM, Yancey Gillespie G.

J Neurooncol. 2009 Nov;95(2):199-209. doi: 10.1007/s11060-009-9926-0. Epub 2009 Jun 12.

15.

Coronavirus genetically redirected to the epidermal growth factor receptor exhibits effective antitumor activity against a malignant glioblastoma.

Verheije MH, Lamfers ML, Würdinger T, Grinwis GC, Gerritsen WR, van Beusechem VW, Rottier PJ.

J Virol. 2009 Aug;83(15):7507-16. doi: 10.1128/JVI.00495-09. Epub 2009 May 13.

17.

Histone deacetylase 6 inhibition enhances oncolytic viral replication in glioma.

Nakashima H, Kaufmann JK, Wang PY, Nguyen T, Speranza MC, Kasai K, Okemoto K, Otsuki A, Nakano I, Fernandez S, Goins WF, Grandi P, Glorioso JC, Lawler S, Cripe TP, Chiocca EA.

J Clin Invest. 2015 Nov 2;125(11):4269-80. doi: 10.1172/JCI80713. Epub 2015 Oct 20.

18.

A molecular approach to the identification of cytotoxic T-lymphocyte epitopes within equine herpesvirus 1.

Kydd JH, Davis-Poynter NJ, Birch J, Hannant D, Minke J, Audonnet JC, Antczak DF, Ellis SA.

J Gen Virol. 2006 Sep;87(Pt 9):2507-15.

PMID:
16894188
19.

Viruses, gene therapy and stem cells for the treatment of human glioma.

Kyritsis AP, Sioka C, Rao JS.

Cancer Gene Ther. 2009 Oct;16(10):741-52. doi: 10.1038/cgt.2009.52. Epub 2009 Jul 31. Review.

PMID:
19644531
20.

The chicken chorioallantoic membrane tumor assay as model for qualitative testing of oncolytic adenoviruses.

Durupt F, Koppers-Lalic D, Balme B, Budel L, Terrier O, Lina B, Thomas L, Hoeben RC, Rosa-Calatrava M.

Cancer Gene Ther. 2012 Jan;19(1):58-68. doi: 10.1038/cgt.2011.68. Epub 2011 Oct 21.

PMID:
22015640

Supplemental Content

Support Center